Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Oct 16;13(10):e18827.
doi: 10.7759/cureus.18827. eCollection 2021 Oct.

Risk of Mucormycosis in Diabetes Mellitus: A Systematic Review

Affiliations
Review

Risk of Mucormycosis in Diabetes Mellitus: A Systematic Review

Manish Khanna et al. Cureus. .

Abstract

Hyperglycemia or diabetes mellitus (DM) is a disorder of the endocrine system. In this condition, the body is insulin-deficient or resistant to insulin. Due to insulin deficiency or resistance, the body is unable to process sugar. The worldwide prevalence of diabetes mellitus is rising substantially. Hyperglycemia makes the immune system weak, which increases the risk of infection in a diabetic patient. Fungal infection is more common in DM. Mucormycosis is a rare fungal infection in a healthy individual, but in DM, it can cause severe complications and even be fatal if not treated adequately and timely. In our literature review, a total of 19 published articles from the PubMed database and Google Scholar were included. We combed the PubMed database and Google Scholar by using various inclusion and exclusion criteria. The result of the review study shows the increased risk of mucormycosis in a diabetic patient.

Keywords: black fungus; diabetes mellitus; diabetes mellitus and immunity; management of mucormycosis; mucormycosis.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram.

References

    1. Differentiation of diabetes by pathophysiology, natural history, and prognosis. Skyler JS, Bakris GL, Bonifacio E, et al. Diabetes. 2017;66:241–255. - PMC - PubMed
    1. Pathophysiology of type 2 diabetes mellitus. Galicia-Garcia U, Benito-Vicente A, Jebari S, et al. Int J Mol Sci. 2020;21:6275. - PMC - PubMed
    1. Global epidemiology of mucormycosis. Prakash H, Chakrabarti A. J Fungi (Basel) 2019;5:26. - PMC - PubMed
    1. Disease entities in mucormycosis. Serris A, Danion F, Lanternier F. J Fungi (Basel) 2019;5:23. - PMC - PubMed
    1. Diabetes, COVID 19 and mucormycosis: clinical spectrum and outcome in a tertiary care medical center in Western India. Mishra Y, Prashar M, Sharma D, Akash Akash, Kumar VP, Tilak TV. Diabetes Metab Syndr. 2021;15:102196. - PMC - PubMed

LinkOut - more resources